Leap Therapeutics Inc (LPTX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -664.3 | -168.76 | -96.136 | -250.803 | -121.607 | -47.117 | -57.999 | -113.724 |
Return on Equity (%) | 30.063 | 67.264 | -228.05 | -895.745 | -167.422 | -52.527 | -65.481 | -136.822 |
Return on Invested Capital (%) | 31.707 | 69.458 | -354.63 | -1806.535 | -138.056 | -54.301 | -69.191 | -149.649 |
Operating Margin (%) | N/A | N/A | N/A | N/A | -1831.8 | -2704.667 | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | -2505.867 | -2705.8 | N/A | N/A |
Book Value Per Share | -1.94 | 0.203 | 0.161 | -0.026 | 0.458 | 0.826 | 0.417 | 0.886 |
Earnings Per Share | -0.496 | -0.549 | -0.406 | -0.5 | -0.369 | -0.311 | -0.386 | -1.2 |
Cash Per Share | 0.015 | 0.471 | 0.286 | 0.059 | 0.511 | 0.88 | 0.464 | 1.041 |
Working Capital Per Share | -0.622 | 0.395 | 0.191 | -0.064 | 0.44 | 0.818 | 0.401 | 0.868 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | 0.015 | 0.011 | N/A | N/A |
EBIT Per Share | -0.496 | -0.547 | -0.406 | -0.495 | -0.27 | -0.311 | -0.385 | -1.2 |
EBITDA Per Share | -0.496 | -0.547 | -0.406 | -0.495 | -0.27 | -0.311 | -0.385 | -1.2 |
Free Cash Flow Per Share | -0.494 | -0.548 | -0.407 | -0.5 | -0.369 | -0.311 | -0.386 | -1.2 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 9,37M | 12,35M | 14,7M | 24,2M | 59,66M | 88,32M | 99,02M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 99,02M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 114,19M |
Ratio cours/bénéfice | -1,39 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1,6 |
Ratio prix/valeur comptable | 1,88 |
Rendement de dividende | - |
Actions en circulation | 38,32M |
Volume moyen (1 semaine) | 160,21k |
Volume moyen (1 mois) | 398,44k |
Variation sur 52 semaines | -25,56% |
Plus haut sur 52 semaines | 5,00 |
Plus bas sur 52 semaines | 1,68 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales